EphB4 Antibodies

Santa Cruz Biotechnology features a diverse variety of EphB4 monoclonal antibodies for research in understanding EphB4's role in various biological processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EphB4 is a member of the Eph receptor family, which plays a vital role in cell signaling and communication, particularly in the development of the nervous system and the regulation of angiogenesis. EphB4 mediates cell-cell interactions and has been linked to various pathological conditions, including cancer progression and metastasis. Research has shown that EphB4 signaling pathways influence cellular behavior, tissue organization, and disease development. Scientists continue to uncover new functions of EphB4 in both normal physiological processes and disease states. Understanding EphB4's molecular mechanisms provides valuable insights into potential therapeutic strategies. Ongoing studies of EphB4 contribute significantly to our understanding of cellular communication and disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific knowledge and develop innovative therapeutic approaches in EphB4-related research.